IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Germany Joins U.S. in Recall of Contaminated Heparin

3:29 PM MDT | March 17, 2008 | Alex Scott

Potentially lethal contaminated batches of the blood-thinning drug heparin have been discovered on the market in Germany. Producers have recalled heparin supplies from the German market following severe reactions to batches of the drug by up to 100 patients. The contamination cases in Germany follow the U.S. withdrawal last month of contaminated batches of heparin that have been linked to 19 patient deaths and up to 800 patients reporting adverse health effects. Villax: Enforcement is inadequate. U.S. officials have traced the contaminated heparin back to...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa